This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: The Innovative Journey of Paul Chirichella in Bone Regeneration
Introduction
Paul Chirichella is an accomplished inventor based in Fair Lawn, NJ, who has made significant strides in the field of medical innovation. With two patents to his name, he has focused his research on the therapeutic applications of insulin-mimetic compounds for promoting bone healing and regeneration. His work reflects a commitment to improving patient outcomes through innovative scientific solutions.
Latest Patents
Chirichella's latest patents delve into the use of insulin-mimetic agents as therapeutic adjuncts for bone regeneration. The patents describe methods for promoting bone healing by locally administering these agents to patients. Additionally, new uses of insulin-mimetic compounds are disclosed for accelerating bone-healing processes. His inventions also encompass devices, products, and kits designed for local administration of these insulin-mimetic agents to enhance treatment for patients suffering from bone injuries.
Career Highlights
Paul Chirichella is affiliated with Rutgers, The State University of New Jersey, a prominent research institution where he works on groundbreaking projects aimed at harnessing the potential of insulin-mimetic agents. His dedication to innovative research has garnered attention in the medical community, contributing to advancements in treatments for bone injuries.
Collaborations
Throughout his career, Chirichella has collaborated with esteemed colleagues such as Sheldon Suton Lin and David Naisby Paglia. These partnerships have been instrumental in advancing his research and expanding the possibilities for applying insulin-mimetic compounds in clinical settings.
Conclusion
In summary, Paul Chirichella stands out as a significant figure in the realm of medical inventions with his focus on insulin-mimetic compounds for bone regeneration. His innovative patents and collaborative efforts continue to pave the way for new treatment methodologies, underscoring the importance of research and development in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile